Lung cancer meningeal metastasis can take gefitinib, ositinib and other drugs. 1. Gefitinib: this product can inhibit tumor growth, tumor metastasis and tumor angiogenesis, and can increase tumor cell death, mainly used in the treatment of metastatic non-small cell lung cancer patients. It is contraindicated in patients with severe hypersensitivity reactions. Adverse reactions may include diarrhea, itchy rash, dry skin, and acne. Acute interstitial lung disease can occasionally occur when taking this product and should be noted. 2. Oshitinib is used in the treatment of non-small cell advanced lung cancer, this product is an oral drug, which is more effective in the treatment of advanced lung cancer patients after drug resistance. Adverse reactions can be constipation, nausea, stomatitis, loss of appetite, dyspepsia, dry skin, blurred vision, fatigue, back pain, headache and so on. It is prohibited for people who are allergic to this product. Patients with meningeal metastasis of lung cancer should continue to consult the doctor, do not self-medicate to avoid adverse results, and use the medicine according to the standard under the guidance of physician’s interview, do not take the medicine by yourself.